Practice Guideline Briefs
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2006 Dec 1;74(11):1970.
Meningococcal Vaccine Supply Increased; Deferral Request Lifted
The manufacturer of tetravalent meningococcal conjugate vaccine (MCV4; Menactra) reports that previous limitations in the vaccine supply have resolved. Therefore, the Centers for Disease Control and Prevention (CDC) recommends that physicians resume routine vaccination according to recommendations from the Advisory Committee on Immunization Practices. Groups that should be vaccinated include children 11 to 12 years of age, adolescents entering high school (if not previously vaccinated), and college freshmen living in dormitories. Because of problems with vaccine supply, the CDC recommended in May 2006 that physicians defer vaccination of children 11 to 12 years of age. The CDC now recommends that physicians recall these patients for vaccination, if possible.
Copyright © 2006 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions